Cooper Companies | COO - Selling And Administration Expenses

Stock Price
82.42
Daily Change
-1.65 -1.96%
Monthly
-0.15%
Yearly
-6.85%
Q1 Forecast
81.46

Cooper Companies reported $419.2M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Abbott USD 3.13B 125M Dec/2025
Align Technology USD 441.68M 23.88M Dec/2025
AtriCure USD 78.34M 109K Dec/2025
Avanos Medical USD 77.6M 5.9M Sep/2025
Bausch Health Companies USD 801M 6M Dec/2025
Baxter International USD 761M 53M Dec/2025
Bayer EUR 3.4B 140M Sep/2025
Becton, Dickinson and Co. USD 1.39B 27M Dec/2025
Boston Scientific USD 1.83B 93M Dec/2025
Cooper Companies USD 419.2M 12M Sep/2025
Dentsply International USD 355M 21M Sep/2025
Dexcom USD 299.9M 31.5M Dec/2025
Edwards Lifesciences USD 602.9M 88.3M Dec/2025
Globus Medical USD 313.6M 9.98M Sep/2025
Haemonetics USD 109.15M 7.54M Dec/2025
Hologic USD 2.5B 2.24B Dec/2025
Inogen USD 43.77M 510K Jun/2024
Insulet USD 331.4M 16.2M Dec/2025
Integra LifeSciences USD 169.05M 10.84M Sep/2025
Intuitive Surgical USD 687.1M 113.8M Dec/2025
J&J USD 6.75B 831M Dec/2025
Medtronic 2.97B 159M Sep/2025
Merit Medical Systems USD 107.38M 5.72M Sep/2025
Novartis USD 3.3B 137M Sep/2025
ResMed USD 278.4M 19.2M Dec/2025
STAAR Surgical USD 59.38M 18.08M Sep/2025
Steris USD 352.3M 2.6M Dec/2025
Stryker USD 2.14B 150M Dec/2025
Tandem Diabetes Care USD 99.86M 5.34M Dec/2025
Teleflex USD 281.76M 66.68M Sep/2025
Utah Medical Products USD 1.87M 50K Sep/2024
Zimmer Biomet Holdings USD 855.7M 44.3M Dec/2025